We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$5.17B
AUM Growth
-$207M
Cap. Flow
-$177M
Cap. Flow %
-3.41%
Top 10 Hldgs %
5.98%
Holding
1,388
New
128
Increased
302
Reduced
333
Closed
82

Top Buys

Rank Stock Value
1
HSY icon
Hershey
HSY
+$13.1M
2
K
Kellanova
K
+$12.1M
3
ADI icon
Analog Devices
ADI
+$11.9M
4
CNP icon
CenterPoint Energy
CNP
+$11.7M
5
AZO icon
AutoZone
AZO
+$10.9M

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$16.9M
2
CAT icon
Caterpillar
CAT
+$15M
3
COR icon
Cencora
COR
+$14.7M
4
COP icon
ConocoPhillips
COP
+$14.3M
5
JPM icon
JPMorgan Chase
JPM
+$12.8M

Sector Composition

Rank Sector Weight
1 Financials 25.4%
2 Industrials 11.68%
3 Energy 11.22%
4 Consumer Discretionary 10.43%
5 Technology 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZVO
1101
DELISTED
Zovio Inc. Common Stock
ZVO
$278K 0.01%
338,700
– –
AAOI icon
1102
Applied Optoelectronics
AAOI
$11.5B
$274K 0.01%
75,000
-55,000
-42% -$213K
EVOL
1103
DELISTED
Evolving Systems, Inc.
EVOL
$274K 0.01%
150,500
– –
ADBE icon
1104
Adobe
ADBE
$105B
$273K 0.01%
600
– –
VHC icon
1105
VirnetX Holding Corp
VHC
$63.1M
$273K 0.01%
8,365
-4,885
-37% -$200K
TCRR
1106
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$272K 0.01%
+98,400
New +$310K
ALLK
1107
DELISTED
Allakos
ALLK
$271K 0.01%
+47,600
New +$308K
HOOK
1108
DELISTED
HOOKIPA Pharma
HOOK
$271K 0.01%
11,880
+2,000
+20% +$35.8K
LYRA
1109
DELISTED
LYRA THERAPEUTICS INC
LYRA
$269K 0.01%
1,338
– –
ELVN icon
1110
Enliven Therapeutics
ELVN
$4.43B
$267K 0.01%
35,500
+4,200
+13% +$27.7K
KLXE icon
1111
KLX Energy Services
KLXE
$42.3M
$267K 0.01%
51,702
– –
TACT icon
1112
Transact Technologies
TACT
$58.5M
$266K 0.01%
37,623
-20,300
-35% -$180K
ELTX icon
1113
Elicio Therapeutics
ELTX
$83.8M
$265K 0.01%
+12,500
New +$282K
LFMD icon
1114
LifeMD
LFMD
$172M
$265K 0.01%
75,000
-25,000
-25% -$88.8K
UBX
1115
DELISTED
Unity Biotechnology
UBX
$265K 0.01%
23,645
+2,800
+13% +$31.4K
APT icon
1116
Alpha Pro Tech
APT
$53.1M
$264K 0.01%
62,900
+21,900
+53% +$102K
CVR icon
1117
Chicago Rivet & Machine Co
CVR
$10.2M
$264K 0.01%
10,000
– –
NH
1118
DELISTED
NantHealth, Inc
NH
$262K 0.01%
23,167
– –
CRVS icon
1119
Corvus Pharmaceuticals
CRVS
$1.17B
$261K 0.01%
159,300
-65,000
-29% -$119K
LRMR icon
1120
Larimar Therapeutics
LRMR
$432M
$254K ﹤0.01%
62,800
– –
SGRP
1121
DELISTED
SPAR Group
SGRP
$253K ﹤0.01%
194,637
– –
WVFC
1122
DELISTED
WVS Financial Corp
WVFC
$253K ﹤0.01%
16,800
– –
PJT icon
1123
PJT Partners
PJT
$4.38B
$252K ﹤0.01%
4,000
– –
MCBC
1124
DELISTED
Macatawa Bank Corp
MCBC
$252K ﹤0.01%
28,000
– –
SIEN
1125
DELISTED
Sientra, Inc.
SIEN
$251K ﹤0.01%
+11,300
New +$310K
43 44
45
46 47

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Bridgeway Capital Management held 1,388 positions worth $5.17B, down 3.9% from $5.38B the previous quarter. Its ten largest holdings account for 6% of the portfolio.

Bridgeway Capital Management withdrew a net $177M in Q1 2022, closing 82 positions and reducing 333 holdings. Its most notable exit was US Bancorp, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Energy.

Against the trend, Bridgeway Capital Management opened a new position in Hershey worth $14M.

  • Bridgeway Capital Management's largest Q1 2022 buy was Hershey: 64,550 shares worth $14M.
  • Bridgeway Capital Management added most to Kellanova in Q1 2022, an estimated $12.1M increase.
  • Bridgeway Capital Management's biggest Q1 2022 reduction was ConocoPhillips, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited US Bancorp in Q1 2022, selling an estimated $16.9M.
  • Bridgeway Capital Management's ten largest holdings make up 6% of its $5.17B portfolio in Q1 2022.
  • Bridgeway Capital Management opened 128 new positions and closed 82 in Q1 2022.
  • Bridgeway Capital Management's portfolio value fell 3.9% quarter-over-quarter to $5.17B.

Based on Bridgeway Capital Management's 13F filing for Q1 2022, filed 16 May 2022.